OBEMIRISK – Knowledge platform for assessing the risk of bisphenols on gut microbiota and its role in obesogenic phenotype: looking for biomarkers
The OBEMIRISK project responds to an “EFSA Partnering Grant” call. Its main objective is to develop a European platform for assessing the risks linked to Bisphenol A (BPA) and its analogues (BPS, BPF, etc.) in children, with an emphasis on the effects on the intestinal microbiota (dysbiosis) and the search for biomarkers in the predisposition to obesity.
- Researcher: Margarita Aguilera Gomez / Ana Rivas Velasco
- Group: TEC16-ADVANCED THERAPIES: DIFFERENCE-REGENATION-CANCER / E15-NUTRITION, DIET, RISK ASSESSMENT
- Centre: University of Grenada
- Role in the project: Project coordinator
- Duration: 2018 – 2021
Project website: https://www.efsa.europa.eu/en